# Food Effect Study of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia

> **NCT06036108** · PHASE1 · COMPLETED · sponsor: **Otsuka Pharmaceutical Co., Ltd.** · enrollment: 59 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** OPC-34712FUM/ Brexpiprazole fumarate
- **DRUG:** OPC-34712FUM/ Brexpiprazole fumarate

## Key facts

- **NCT ID:** NCT06036108
- **Lead sponsor:** Otsuka Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-03
- **Primary completion:** 2025-03-18
- **Final completion:** 2025-04-08
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2026-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06036108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06036108, "Food Effect Study of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06036108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*